English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/128806
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Conformationally-Locked C-Glycosides: Tuning Aglycone Interactions for Optimal Cheperone Behaviour in Gaucher Fibroblasts

AuthorsNavo, C.D.; Corzana, F.; Sánchez-Fernández, Elena M. ; Busto, J.H.; Avenoza, A.; Namba, E.; Higaki, Katsumi; Ortiz-Mellet, Carmen; García-Fernández, José Manuel; Peregrina, J.M.
Issue Date2016
PublisherRoyal Society of Chemistry
CitationOrganic and Biomolecular Chemistry, 14(4): 1474-1484 (2016)
AbstractA series of conformationally locked C-glycosides based on the 3-aminopyrano[3,2-b]pyrrol-2(1H)-one (APP) scaffold has been synthesized. The key step involved a totally stereocontrolled C-Michael addition of a serine-equivalent C-nucleophile to tri-O-benzyl-2-nitro-D-galactal, previously published by the authors. Stereoselective transformations of the Michael adduct allowed us the synthesis of compounds with mono- or diantennated aglycone moieties and different topologies. In vitro screening showed highly selective inhibition of bovine liver β-glucosidase/β-galactosidase and specific inhibition of human β-glucocerebrosidase among lysosomal glycosidases for compounds bearing palmitoyl chains in the aglycone, with a marked dependence of the inhibition potency upon their number and location. Molecular dynamics simulations highlighted the paramount importance of an optimal orientation of the hydrophobic substituent to warrant efficient non-glycone interactions, which are critical for the binding affinity. The results provide a rationale for the strong decrease of the inhibition potency of APP compounds on going from neutral to acidic pH. The best candidate was found to behave as pharmacological chaperone in Gaucher fibroblasts with homozygous N370S and F213I mutations, with enzyme activity enhancements similar to those encountered for the reference compound Ambroxol®
Publisher version (URL)http://dx.doi.org/10.1039/C5OB02281A
URIhttp://hdl.handle.net/10261/128806
DOI10.1039/C5OB02281A
Appears in Collections:(IIQ) Artículos
Files in This Item:
File Description SizeFormat 
OBC_APP derivatives_JMGF_2.docx5,53 MBMicrosoft Word XMLView/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.